ATE106733T1 - In der therapeutik anwendbare zusammensetzung mit aggregationshemmender wirkung auf blutplättchen. - Google Patents

In der therapeutik anwendbare zusammensetzung mit aggregationshemmender wirkung auf blutplättchen.

Info

Publication number
ATE106733T1
ATE106733T1 AT90400605T AT90400605T ATE106733T1 AT E106733 T1 ATE106733 T1 AT E106733T1 AT 90400605 T AT90400605 T AT 90400605T AT 90400605 T AT90400605 T AT 90400605T AT E106733 T1 ATE106733 T1 AT E106733T1
Authority
AT
Austria
Prior art keywords
platelets
therapeutics
aggregation activity
composition applicable
composition
Prior art date
Application number
AT90400605T
Other languages
German (de)
English (en)
Inventor
Jesus Covarrubias
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Application granted granted Critical
Publication of ATE106733T1 publication Critical patent/ATE106733T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90400605T 1989-03-10 1990-03-06 In der therapeutik anwendbare zusammensetzung mit aggregationshemmender wirkung auf blutplättchen. ATE106733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903138A FR2644061A1 (fr) 1989-03-10 1989-03-10 Composition a activite antiagregante plaquettaire utilisable en therapeutique

Publications (1)

Publication Number Publication Date
ATE106733T1 true ATE106733T1 (de) 1994-06-15

Family

ID=9379557

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400605T ATE106733T1 (de) 1989-03-10 1990-03-06 In der therapeutik anwendbare zusammensetzung mit aggregationshemmender wirkung auf blutplättchen.

Country Status (10)

Country Link
EP (1) EP0387140B1 (enExample)
JP (1) JP2935138B2 (enExample)
KR (1) KR0169118B1 (enExample)
AT (1) ATE106733T1 (enExample)
CA (1) CA2027593C (enExample)
DE (1) DE69009538T2 (enExample)
ES (1) ES2058832T3 (enExample)
FR (1) FR2644061A1 (enExample)
MX (1) MX174250B (enExample)
WO (1) WO1990010447A1 (enExample)

Also Published As

Publication number Publication date
JPH03504509A (ja) 1991-10-03
DE69009538T2 (de) 1995-01-12
KR0169118B1 (ko) 1999-01-15
EP0387140B1 (fr) 1994-06-08
WO1990010447A1 (fr) 1990-09-20
ES2058832T3 (es) 1994-11-01
FR2644061B1 (enExample) 1994-04-22
JP2935138B2 (ja) 1999-08-16
EP0387140A1 (fr) 1990-09-12
CA2027593A1 (fr) 1990-09-11
KR920700037A (ko) 1992-02-19
FR2644061A1 (fr) 1990-09-14
DE69009538D1 (de) 1994-07-14
MX174250B (es) 1994-05-02
CA2027593C (fr) 2001-01-02

Similar Documents

Publication Publication Date Title
ATE135234T1 (de) Hemmung von arteriellem thrombotischen verschluss oder von thrombo-embolismus
DE3871544D1 (de) Parfuemierendes praeparat mit desodorierender oder schweisshemmender wirkung.
DE59107331D1 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
ATE69548T1 (de) Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
ATE86490T1 (de) Tracheobronchodilatator.
ES2068935T3 (es) Piridazinonas con actividad insecticida y acaricida y composiciones que las contienen.
ATE104151T1 (de) Trombosebehandlung mit fibrinolytika und prostacyclinen.
NO871053D0 (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
ATE106733T1 (de) In der therapeutik anwendbare zusammensetzung mit aggregationshemmender wirkung auf blutplättchen.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DK24687D0 (da) 3-alkoxyflavonderivater samt antiviralt virksomme terapeutiske midler indeholdende disse
ES2039735T3 (es) Agente para la profilaxia del infarto cardiaco y para la prevencion del reinfarto.
BE849004A (fr) Quinoleines douees d'activite antalgique utilisables dans le traitement d'algies diverses
DE3862486D1 (de) Fungizide mischungen mit prochloraz.
NO871198L (no) Anvendelse av substituerte n-(triklormetyltiohydantoiner i kombinasjon med bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
AR219071A1 (es) Metodo para preparar derivados de benzimidazol-2-carbamato sustituidos en la posicion 5 o 6 del anillo bencenico que tienen actividad antihelmintica
DE68926334D1 (de) Textilbehandlungsmittel
DK181089D0 (da) 1-dimethylcarbamoyl-3-substituerede-5-substituerede-1h-1,2,4-triazoler
USD239500S (en)
AT379344B (de) Holzspalter mit zweiteiligem hubbalken
ES2054599T1 (es) Utilizacion de valina-dl, sus esteres y/o sales para combatir la caspa.
DK301589A (da) Laegemiddel med thrombolytisk virkning
SE8701177L (sv) Arbetsmoebel med staellbart stativ

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties